Compound Summary
yc-1
Compound Information
yc-1
Compound Name: | yc-1 |
Compound CID: | 5712 |
Synonyms: | yc-1 Lificiguat 170632-47-0 YC 1 3-(5-Hydroxymethyl-2-furyl)-1-benzylindazole More... |
Iupac Name: | [5-(1-benzylindazol-3-yl)furan-2-yl]methanol |
InChI: | InChI=1S/C19H16N2O2/c22-13-15-10-11-18(23-15)19-16-8-4-5-9-17(16)21(20-19)12-14-6-2-1-3-7-14/h1-11,22H,12-13H2 |
InChIKey: | OQQVFCKUDYMWGV-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)C4=CC=C(O4)CO |
Isomeric Smiles: | C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)C4=CC=C(O4)CO |
Molecular Weight: | 304.3 |
Molecular Formula: | C19H16N2O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
yc-1
Molecular Weight: | 304.3 |
Molecular Formula: | C19H16N2O2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 23 |
Complexity: | 386 |
Synonyms
yc-1
| yc-1 | yc-1 |
|---|---|
yc-1 |
Lificiguat |
170632-47-0 |
YC 1 |
3-(5-Hydroxymethyl-2-furyl)-1-benzylindazole |
(5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol |
UNII-515CC1WPTE |
154453-18-6 |
5-(1-benzylindazol-3-yl)furan-2-ylmethanol |
515CC1WPTE |
CHEMBL333985 |
3-(5-Hydroxymethyl-2-furyl)-1-benzyl indazole |
5-1-(Phenylmethyl)-1H-indazol-3-yl-2-furanmethanol |
YC1 |
1-Benzyl-3-(5-hydroxymethyl-2-furyl)indazole |
5-(1-benzyl-1H-indazol-3-yl)furan-2-ylmethanol |
3-(5/-hydroxymethyl-2/-furyl)-1-benzylindazole |
5-1-(phenylmethyl)indazol-3-ylfuran-2-ylmethanol |
YC 1 compound |
YC-1 compound |
Lificiguat INN |
SMR000857214 |
Lificiguat(YC-1) |
SR-01000076202 |
5-(1-benzyl-1h-indazol-3-yl)-2-furylmethanol |
lificiguatum |
YC-1(Lificiguat) |
YC-1; Lificiguat |
YC-1, powder |
2-Furanmethanol,5-1-(phenylmethyl)-1H-indazol-3-yl- |
Lopac-Y-102 |
Lopac0_001230 |
BSPBio_000987 |
KBioGR_000327 |
KBioSS_000327 |
MLS001333257 |
MLS001333258 |
MLS002172480 |
MLS006012048 |
SCHEMBL187837 |
GTPL5291 |
CHEBI:93060 |
KBio2_000327 |
KBio2_002895 |
KBio2_005463 |
KBio3_000653 |
KBio3_000654 |
DTXSID70165635 |
CHEBI:142430 |
3-(5′-Hydroxymethyl-2′-furyl)-1-benzylindazole |
Bio2_000324 |
Bio2_000804 |
HMS1362A09 |
HMS1792A09 |
HMS1990A09 |
HMS2235B17 |
HMS3263F22 |
HMS3373B12 |
HMS3403A09 |
HMS3649M04 |
KUC114162N |
BCP09072 |
EX-A2409 |
VGA63247 |
ZINC1492386 |
Tox21_501230 |
4164AH |
BDBM50095469 |
MFCD06407798 |
NSC728165 |
NSC756879 |
s7958 |
AKOS022180370 |
CCG-205304 |
CS-3363 |
LP01230 |
NSC 728165 |
NSC-728165 |
NSC-756879 |
SDCCGSBI-0051197.P002 |
IDI1_002079 |
QTL1_000091 |
NCGC00016103-01 |
NCGC00016103-02 |
NCGC00016103-03 |
NCGC00016103-04 |
NCGC00016103-05 |
NCGC00016103-06 |
NCGC00016103-07 |
NCGC00016103-17 |
NCGC00094472-01 |
NCGC00094472-02 |
NCGC00094472-03 |
NCGC00094472-04 |
NCGC00261915-01 |
AC-29036 |
AS-55797 |
DA-29768 |
HY-14927 |
KSC-412-005- |
B7641 |
EU-0101230 |
FT-0757306 |
Y-102 |
1-Benzyl-3-(5-hydroxymethylfur-2-yl)indazole |
1-Benzyl-3-(5-hydroxymethyl-2-furyl)indazole" |
3-(5-hydroxymethyl-2furyl)-1-benzyl-indazole |
A907557 |
1-Benzyl-3-(5-hydroxymethyl-2-furyl)-1H-indazole |
J-010636 |
SR-01000076202-1 |
SR-01000076202-7 |
BRD-K60476892-001-02-1 |
BRD-K60476892-001-11-2 |
Q27089256 |
5-(1-Benzyl-1H-indazol-3-yl)-furan-2-yl-methanol |
1-(1-benzyl-3-(5-hydroxymethyl-2-furyl)-indazole |
2-Furanmethanol, 5-1-(phenylmethyl)-1H-indazol-3-yl- |
5-a1-a?phenylmethyl)-a?H-aindazol-a?-ayl-a?-afuranmethanol |
Experimental Data
yc-1
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -6.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
yc-1
Statistics Data
yc-1
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -6.000000000000000 | 1 | 1 |
Statistics Data Visualization
yc-1
